N

Novo Nordisk

  • Founded1923 (as Nordisk Insulinlaboratorium); Novo Nordisk formed by merger in 1989
  • HeadquartersBagsværd, Denmark (U.S. headquarters: Plainsboro, New Jersey)
  • IndustryPharmaceutical manufacturer
Official website

TirzaSema has no affiliate or commercial relationship with Novo Nordisk.

Novo Nordisk is a Danish pharmaceutical company that makes the semaglutide medicines Wegovy and Ozempic. In the United States, it sells these medicines to self-pay patients through NovoCare Pharmacy, its direct-to-patient pharmacy service.

TirzaSema has no affiliate or commercial relationship with Novo Nordisk.

Products

Once-weekly semaglutide injection from Novo Nordisk, FDA-approved for type 2 diabetes and related heart and kidney risk reduction. Not approved for weight management. Self-pay…

$349/mo

Once-weekly semaglutide injection from Novo Nordisk. FDA-approved for chronic weight management, cardiovascular risk reduction and noncirrhotic MASH with fibrosis. Self-pay from $349/month via NovoCare…

$349/mo

Once-daily oral semaglutide tablet from Novo Nordisk, FDA-approved December 2025 for weight management and cardiovascular risk reduction in adults. Self-pay $149 to $299/month by…

$149/mo